The Centers for Medicare and Medicaid Services (CMS) has included Ozempic among the next 15 drugs chosen for Medicare ...

Teva Pharmaceutical Industries sues CMS over Medicare drug pricing negotiations policy, claiming agency has unchecked ...

The Centers for Medicare & Medicaid Services Jan. 17 announced a record 24.2 million consumers selected health coverage ...

In the final days of the Biden administration, the U.S. Department of Health and Human Services’ Centers for Medicare and ...

CMS didn't wait for President-elect Donald Trump to take office before issuing its second list of drugs to be negotiated ...

Kurnool: Former MP TG Venkatesh rubbished the speculation that thespian Chiranjeevi would join the BJP. We cannot say that ...

Teva Pharmaceuticals is suing the Centers for Medicare & Medicaid Services (CMS) for its implementation of the drug price ...

The Quality Pathway can drive greater care improvements through the use of multiple complementary levers of change, such as ...

The work of the Innovation Center has benefited from continuity across administrations; the path to further expanding ...

Alignment Healthcare is the latest Medicare Advantage (MA) insurer to accuse the Centers for Medicare & Medicaid Services ...

The conversion of Calquence’s accelerated approval in mantle cell lymphoma comes a day before the drug was listed among the ...

CMS has released its official 2025 mission and priorities document outlining its roadmap for state survey agencies Monday.